Arax Advisory Partners’s Molina Healthcare MOH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.75M Buy
25,163
+22,091
+719% +$4M 0.04% 446
2026
Q1
$439K Buy
3,072
+2,877
+1,475% +$458K 0.01% 697
2025
Q4
$33.8K Sell
195
-42,630
-100% -$7.01M ﹤0.01% 1829
2025
Q3
$8.19M Buy
42,825
+42,608
+19,635% +$7.84M 0.12% 134
2025
Q2
$64.6K Sell
217
-61
-22% -$19.2K ﹤0.01% 1121
2025
Q1
$91.6K Sell
278
-315
-53% -$95.1K 0.01% 754
2024
Q4
$173K Buy
593
+445
+301% +$137K 0.01% 530
2024
Q3
$51K Buy
148
+120
+429% +$39.6K ﹤0.01% 712
2024
Q2
$8.32K Buy
28
+26
+1,300% +$8.83K ﹤0.01% 1359
2024
Q1
$822 Hold
2
﹤0.01% 1181
2023
Q4
$723 Hold
2
﹤0.01% 1179
2023
Q3
$656 Hold
2
﹤0.01% 1205
2023
Q2
$603 Sell
2
-1
-33% -$287 ﹤0.01% 1183
2023
Q1
$803 Hold
3
﹤0.01% 1135
2022
Q4
$991 Sell
3
-1
-25% -$340 ﹤0.01% 1073
2022
Q3
$1K Hold
4
﹤0.01% 1115
2022
Q2
$1K Buy
+4
New +$1.21K ﹤0.01% 1077

Other funds holding MOH

Arax Advisory Partners's MOH Position: Q2 2026 in Review

Arax Advisory Partners increased its Molina Healthcare (MOH) stake by 719% in Q2 2026, buying an estimated $4M and bringing the position to 25,163 shares worth $5.75M. The position accounts for 0.04% of the portfolio, ranked #446.

Arax Advisory Partners first reported a position in MOH in Q2 2022 and has held it in 17 quarters since. The position peaked at $8.19M in Q3 2025. 600 funds tracked by Wall St. Rank hold MOH as of Q2 2026.

  • Arax Advisory Partners held 25,163 shares of Molina Healthcare worth $5.75M as of Q2 2026.
  • Arax Advisory Partners bought 22,091 Molina Healthcare shares in Q2 2026, an estimated $4M.
  • Molina Healthcare made up 0.04% of Arax Advisory Partners's portfolio in Q2 2026, its #446 holding.
  • Arax Advisory Partners first reported a position in Molina Healthcare in Q2 2022 and has held it in 17 quarters since.
  • Arax Advisory Partners's Molina Healthcare position peaked at $8.19M in Q3 2025.
  • 600 funds tracked by Wall St. Rank held Molina Healthcare as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.